Best Peptide for Nootropic & Neuroprotective Research
Semax dominates nootropic and neuroprotective research through melanocortin-4 receptor signaling, BDNF and NGF upregulation, and rapid central nervous system bioavailability. The ACTH(4-7)PGP heptapeptide is the established standard for cognitive enhancement and neuroregeneration studies.
TOP RECOMMENDATION
Semax — ACTH(4-7)PGP — Neuroprotective Heptapeptide
Semax is the definitive peptide for nootropic and neuroprotective research. As the synthetic heptapeptide ACTH(4-7)PGP, it combines the core melanocortin sequence of adrenocorticotropic hormone with a Pro-Gly-Pro extension that dramatically enhances blood-brain barrier permeability. Published studies demonstrate Semax upregulates BDNF and NGF in hippocampal and cortical neuronal cultures, promotes synaptic plasticity through MC4R-mediated cAMP/PKA/CREB signaling, and delivers reproducible neuroprotective outcomes in focal cerebral ischemia and optic nerve trauma models. No other peptide in the Ares Research catalog offers this specific melanocortin-CNS mechanism. For cognitive enhancement, memory consolidation, and neuroregeneration research, Semax stands alone as the established standard.
WHY IT WINS
- Upregulates BDNF and NGF expression in hippocampal and cortical neuronal cultures, promoting synaptic plasticity and neurogenesis
- Melanocortin-4 receptor (MC4R) agonism modulates cAMP/PKA/CREB signaling cascade central to memory consolidation and cognitive flexibility
- Pro-Gly-Pro (PGP) C-terminal extension dramatically increases blood-brain barrier permeability compared to native ACTH(4-7)
- Short plasma half-life (~10–20 min) enables precise dose-response and temporal control in acute cognitive assay designs
- Extensively studied in focal cerebral ischemia, optic nerve trauma, and cognitive deficit models with reproducible neuroprotective outcomes
APPLICATION SUITABILITY MATRIX
| RESEARCH APPLICATION | Semax | ALTERNATIVE |
|---|---|---|
| BDNF Upregulation | ||
| NGF Expression | ||
| Synaptic Plasticity | ||
| CNS Bioavailability | ||
| Neuroprotection (Ischemia) | ||
| Memory Consolidation | ||
| Melanocortin Receptor Signaling | ||
| Cost per Experiment |
IDEAL RESEARCH APPLICATIONS
- Hippocampal neuron BDNF/NGF expression assays
- Cognitive deficit and memory consolidation models
- Focal cerebral ischemia and stroke recovery research
- Optic nerve trauma and CNS regeneration studies
- Melanocortin receptor (MC4R) signaling pathway research
NO CLOSE ALTERNATIVE
Semax stands alone in this category.
No other peptide in the Ares Research catalog offers a mechanism specifically relevant to nootropic research. While broader comparisons exist with TB-500 for general tissue repair, the gastric protection mechanism of BPC-157 is unique among our compounds.
ANALYTICAL SPECIFICATIONS
Compound
ACTH(4-7)PGP — Neuroprotective Heptapeptide
CAS Number
80714-61-0
Purity (HPLC)
≥ 99.5%
Molecular Weight
708.82 g/mol
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Verification
HPLC + MS per batch
FREQUENTLY ASKED QUESTIONS
Why is Semax the only peptide for nootropic research in your catalog?
Semax is a melanocortin-4 receptor agonist with demonstrated BDNF/NGF upregulation in CNS neuronal cultures. No other peptide in the Ares Research catalog targets melanocortin receptors or has published neuroprotective efficacy in focal cerebral ischemia models. Its ACTH(4-7)PGP sequence and blood-brain barrier permeability are unique among our compounds.
What concentration of Semax should I use in neuronal cell culture?
For primary cortical or hippocampal neuron cultures, Semax is typically evaluated at 10–100 mcg/ml in neurobasal media with B27 supplement. BDNF and NGF expression are assessed by qPCR, Western blot, or ELISA at 24–72 hours. For acute synaptic plasticity readouts (LTP/LTD), bath application at 1–10 mcg/ml for 30–60 minutes during electrophysiology recording is standard.
Does Semax cross the blood-brain barrier in in-vivo models?
Yes. The Pro-Gly-Pro (PGP) C-terminal extension significantly enhances blood-brain barrier permeability compared to native ACTH(4-7). Radiolabeled distribution studies and CNS tissue concentration assays confirm Semax reaches hippocampal, cortical, and hypothalamic regions after systemic administration in rodent models.
How stable is Semax in neuronal culture media?
Semax is stable in standard neurobasal and DMEM/F12 media at 37°C for 24–48 hours. The Met¹ residue is susceptible to oxidation; replace media daily in longitudinal studies. Reconstituted Semax stock should be aliquoted and stored at -20°C, protected from light, and thawed once.
Can Semax be combined with BDNF in neurotrophic studies?
Yes. Many researchers evaluate Semax alongside recombinant BDNF as a positive control or in combination. Semax upregulates endogenous BDNF expression, while exogenous BDNF provides direct TrkB receptor activation. Typical BDNF concentration is 10–50 ng/ml combined with Semax at 10–50 mcg/ml.
REFERENCES
- [1]Medvedeva, E.V. et al. (2017). Semax and its effects on BDNF expression. Bulletin of Experimental Biology and Medicine, 163(3), 339–342.
- [2]Koroleva, S.V. et al. (2015). Neuroprotective effects of Semax in cerebral ischemia. Neuroscience and Behavioral Physiology, 45(6), 678–684.
- [3]Guseva, M.V. et al. (2010). Effect of Semax on neuronal survival. Cellular and Molecular Neurobiology, 30(3), 381–389.
- [4]Myasoedov, N.F. et al. (2014). Semax: from peptide technology to clinical practice. Russian Journal of Bioorganic Chemistry, 40(6), 663–669.
TOP RECOMMENDATION
Semax
ACTH(4-7)PGP — Neuroprotective Heptapeptide
QUICK LINKS
RELATED RESEARCH GOALS
RESEARCH USE ONLY. All compounds are strictly for in-vitro laboratory research by qualified professionals. Not for human consumption, veterinary use, or clinical application.